FR2734266B1 - PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE - Google Patents

PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE

Info

Publication number
FR2734266B1
FR2734266B1 FR9505753A FR9505753A FR2734266B1 FR 2734266 B1 FR2734266 B1 FR 2734266B1 FR 9505753 A FR9505753 A FR 9505753A FR 9505753 A FR9505753 A FR 9505753A FR 2734266 B1 FR2734266 B1 FR 2734266B1
Authority
FR
France
Prior art keywords
peptides
domain
binding
preparation
nucleotide sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9505753A
Other languages
French (fr)
Other versions
FR2734266A1 (en
Inventor
Bruno Tocque
Marc Duchesne
Didier Faucher
Fabienne Parker
Fabien Schweighoffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9505753A priority Critical patent/FR2734266B1/en
Priority to IL11602695A priority patent/IL116026A/en
Priority to HU9702079A priority patent/HU221410B1/en
Priority to AU42636/96A priority patent/AU713937B2/en
Priority to JP8516632A priority patent/JPH10509044A/en
Priority to ES95941126T priority patent/ES2248800T3/en
Priority to SK629-97A priority patent/SK287034B6/en
Priority to PCT/FR1995/001539 priority patent/WO1996016169A1/en
Priority to AT95941126T priority patent/ATE305037T1/en
Priority to DK95941126T priority patent/DK0793721T3/en
Priority to CZ19971545A priority patent/CZ292538B6/en
Priority to BR9510067A priority patent/BR9510067A/en
Priority to DE69534471T priority patent/DE69534471T2/en
Priority to US08/836,791 priority patent/US5886150A/en
Priority to MX9703364A priority patent/MX9703364A/en
Priority to CA002204438A priority patent/CA2204438A1/en
Priority to EP95941126A priority patent/EP0793721B1/en
Publication of FR2734266A1 publication Critical patent/FR2734266A1/en
Priority to FI972170A priority patent/FI972170A0/en
Priority to NO972313A priority patent/NO972313L/en
Application granted granted Critical
Publication of FR2734266B1 publication Critical patent/FR2734266B1/en
Priority to JP2005309422A priority patent/JP2006122049A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
FR9505753A 1994-11-22 1995-05-16 PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE Expired - Fee Related FR2734266B1 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR9505753A FR2734266B1 (en) 1995-05-16 1995-05-16 PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE
IL11602695A IL116026A (en) 1994-11-22 1995-11-16 Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
US08/836,791 US5886150A (en) 1994-11-22 1995-11-22 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
JP8516632A JPH10509044A (en) 1994-11-22 1995-11-22 Peptide capable of binding to GAP protein SH3 domain, nucleotide sequence encoding the same, and method for producing and using the same
ES95941126T ES2248800T3 (en) 1994-11-22 1995-11-22 PEPTIDES ABLE TO JOIN THE SH3 DOMAIN OF THE GAP PROTEIN, NUCLEOTIDIC CODING SEQUENCES FOR THESE PEPTIDES, THEIR PREPARATION AND THEIR USE.
SK629-97A SK287034B6 (en) 1994-11-22 1995-11-22 Peptides capable of binding to the gap protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
PCT/FR1995/001539 WO1996016169A1 (en) 1994-11-22 1995-11-22 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
AT95941126T ATE305037T1 (en) 1994-11-22 1995-11-22 PEPTIDES CAPABLE OF BINDING THE SH3 DOMAIN OF THE GAP PROTEIN, ITS CODING DNA, THEIR PREPARATION AND USE
DK95941126T DK0793721T3 (en) 1994-11-22 1995-11-22 Peptides capable of binding to the SH3 domain of the GAP protein, nucleotide sequences encoding therefore, production and use thereof
CZ19971545A CZ292538B6 (en) 1994-11-22 1995-11-22 Polypeptide capable of interacting with the GAP protein SH3 domain, antibody directed against the polypeptide, nucleotide sequence encoding such polypeptide, pharmaceutical composition containing the polypeptide and use of the above antibody, polypeptide and the nucleotide
HU9702079A HU221410B1 (en) 1994-11-22 1995-11-22 Polypeptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding thereof, preparation and use thereof
DE69534471T DE69534471T2 (en) 1994-11-22 1995-11-22 PEPTIDES THAT ARE CAPABLE OF BINDING THE SH3 DOMAIN OF THE GAP PROTEIN, THEIR ENCODING DNA, THEIR PREPARATION AND USE
AU42636/96A AU713937B2 (en) 1994-11-22 1995-11-22 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
MX9703364A MX9703364A (en) 1994-11-22 1995-11-22 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof.
CA002204438A CA2204438A1 (en) 1994-11-22 1995-11-22 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
EP95941126A EP0793721B1 (en) 1994-11-22 1995-11-22 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
BR9510067A BR9510067A (en) 1994-11-22 1995-11-22 Peptide capable of interacting with the sh3 domain of the antibody gap protein or antibody fragment directed against a polypeptide nucleotide sequence encoding an antisense nucleic acid polypeptide capable of at least partially inhibiting the production of polypeptides its use pharmaceutical composition and use of an antibody or antibody fragment
FI972170A FI972170A0 (en) 1994-11-22 1997-05-21 Peptides capable of binding to the GAP protein SH3 domain, these peptides encoding nucleotide sequences, preparing and using them
NO972313A NO972313L (en) 1994-11-22 1997-05-21 Peptides capable of binding to the GAP protein SH3 region, nucleotide sequences encoding this, and their production and use
JP2005309422A JP2006122049A (en) 1994-11-22 2005-10-25 Peptide capable of binding to gap protein sh3 domain, nucleotide sequence coding the same, and preparation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505753A FR2734266B1 (en) 1995-05-16 1995-05-16 PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE

Publications (2)

Publication Number Publication Date
FR2734266A1 FR2734266A1 (en) 1996-11-22
FR2734266B1 true FR2734266B1 (en) 1997-06-20

Family

ID=9479004

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9505753A Expired - Fee Related FR2734266B1 (en) 1994-11-22 1995-05-16 PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE

Country Status (1)

Country Link
FR (1) FR2734266B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002749A1 (en) * 1989-08-21 1991-03-07 Cetus Corporation PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
EP0496162A3 (en) * 1990-12-24 1993-09-01 Merck & Co. Inc. Peptide inhibitors of ras-gap interaction
FR2694296B1 (en) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibiting the activity of ras proteins, preparation and use.
AU6083894A (en) * 1993-01-15 1994-08-15 Schering Corporation Ras associated gap proteins

Also Published As

Publication number Publication date
FR2734266A1 (en) 1996-11-22

Similar Documents

Publication Publication Date Title
NO995134L (en) Improved Methods for Preparation of Activated Protein C
AU7473398A (en) Inhibitors of protein isoprenyl transferases
DE69722635D1 (en) TREATMENT OF MATERIALS TO IMPROVE THE TREATMENT OF VISCOELASTIC LIQUIDS
WO2001038547A3 (en) Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
DE59914439D1 (en) Amplitude multiplexing of digital signals
AU6508499A (en) Antisense modulation of microtubule-associated protein 4 expression
AU1221201A (en) Antisense modulation of y-box binding protein 1 expression
AU4367196A (en) Novel protein domain which binds tyrosine phosphorylated proteins
AU9222698A (en) Novel molecules of the tnfr-ligand-related protein family and uses thereof
AU7604196A (en) Novel inhibitors of peptide binding to mhc class ii proteins
DE69802726D1 (en) Deposition of titanium nitride films
MX9703364A (en) Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof.
DE69807466T2 (en) TRIPTOLID DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES
MX9806041A (en) PURIFIED SR-p70 PROTEIN.
ATE285474T1 (en) HAEMOPHILUS ADHESION PROTEINS
PL332282A1 (en) Application of proteins as factors against autoimmunological diseases
DE69837148D1 (en) CHIMERIC PROTEINS FOR THE TREATMENT OF DIABETES
DE69834937D1 (en) ANTIBIOTICS FOR THE TREATMENT OF STOMACHES
FR2734266B1 (en) PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN NUCLEOTIDE SEQUENCES ENCODING FOR SUCH PEPTIDES, THEIR PREPARATION AND USE
FR2721930B1 (en) OLIGONUCLEOTIDES TO INHIBIT THE ROLE OF ISOPRENYL PROTEIN TRANSFERASES
FR2727116B1 (en) PEPTIDES CAPABLE OF BINDING TO THE SH3 DOMAIN OF THE GAP PROTEIN, NUCLEOTID SEQUENCES CODING FOR THESE PEPTIDES, THEIR PREPARATION AND USE
FR2764285B1 (en) NEW BONDING PHASE FOR PHOSPHOMAGNETIC CEMENTS AND THEIR USE FOR THE PREPARATION OF MORTARS
WO1999028465A3 (en) Pias molecules that recognize and bind stat proteins and uses thereof
AU2736801A (en) Binding of polyamides to proteins having sh3 or ww domains
NO20015115D0 (en) Adipocyte complement related protein homologue zacrp3

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20110131